During the past decade, Hopital Saint Jean conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Saint Jean" #1 sponsor was "Celgene" with 2 trials, followed by "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Institut du Cancer de Montpellier - Val d'Aurelle" with 2 trials sponsored and "UNICANCER" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint Jean" #1 collaborator was "CH Bagnols sur Cèze" with 1 trials as a collaborator, "CH Béziers" with 1 trials as a collaborator, "CH Narbonne HÔTEL DIEU" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Centre Hospitalier Saint Jean Perpignan" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Saint Jean" are "Diffuse Large B-cell Lymphoma" (2 trials), "Multiple Myeloma" (2 trials), "Acute Ischemic Stroke" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Aneurysmal Subarachnoid Hemorrhages (aSAH)" (1 trials). Many other conditions were trialed in "Hopital Saint Jean" in a lesser frequency.

Most popular intervention types in "Hopital Saint Jean" are "Drug" (14 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oxaliplatin" (3 trials), "Placebo" (3 trials), "Dexamethasone" (2 trials), "Gemcitabine" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint Jean" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Saint Jean". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hopital Saint Jean, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint Jean, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".